Microbial transformation of antimalarial terpenoids

Biotechnology Advances

Volumn 30, Issue 6, 2012, Pages 1516-1523

  Parshikov, Igor A ^a   Netrusov, Alexander I ^b   Sutherland, John B ^c  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Artemisinin; Biotransformation; Malaria; Plasmodium; Terpenes

Indexed keywords

ARTEMISININ; BIOTRANSFORMATION; MALARIA; PLASMODIUM; TERPENES;

DISEASES; ESSENTIAL OILS; OLEFINS;

LIPIDS;

ANTIMALARIAL AGENT; TERPENE;

BIOTECHNOLOGY; BIOTRANSFORMATION; DISEASE TREATMENT; DRUG DEVELOPMENT; ESSENTIAL OIL; MALARIA; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; PHARMACEUTICAL INDUSTRY; PROTIST; TERPENE;

BACTERIUM; BIOTRANSFORMATION; CHEMISTRY; FUNGUS; METABOLISM; REVIEW;

ANTIMALARIALS; BACTERIA; BIOTRANSFORMATION; FUNGI; TERPENES;

ARTEMISIA ANNUA; BACTERIA (MICROORGANISMS);

EID: 84867718054     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.03.010     Document Type: Review

References (93)

1. Abraham W.-R., Arfmann H.-A. Microbial hydroxylation of activated acyclic monoterpene hydrocarbons. Tetrahedron 1992, 48:6681-6688.
2. Areche C., Loyola L.A., Borquez J., Rovirosa J., San-Martin A. Microbial transformation of the diterpene mulin-11, 13-dien-20-oic acid by Mucor plumbeus. Magn Reson Chem 2008, 46:765-768.
3. Avery M.A., Alvim-Gaston M., Rodrigues C.R., Barreiro E.J., Cohen F.E., Sabnis Y.A., et al. Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies. J Med Chem 2002, 45:292-303.
4. Bastos D.Z.L., Pimentel I.C., Jesus D.A., Oliveira B.H. Biotransformation of betulinic and betulonic acids by fungi. Phytochemistry 2007, 68:834-839.
5. Batista R., Silva A.J., Oliveira A.B. Plant-derived antimalarial agents: new leads and efficient phytomedicines. Part II. Non-alkaloidal natural products. Molecules 2009, 14:3037-3072.
6. Beekman A.C., Wierenga P.K., Woerdenbag H.J., van Uden W., Pras N., Konings A.W.T., et al. Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: cytotoxic action against bone marrow and tumour cells. Planta Med 1998, 64:615-619.
7. Bero J., Frédérich M., Quetin-Leclercq J. Antimalarial compounds isolated from plants used in traditional medicine. J Pharm Pharmacol 2009, 61:1401-1433.
8. Carvalho C.C.C.R., Fonseca M.M.R. Biotransformation of terpenes. Biotechnol Adv 2006, 24:134-142.
9. Carvalho T.C., Polizeli A.M., Turatti I.C.C., Severiano M.E., Carvalho C.E., Ambrósio S.R., et al. Screening of filamentous fungi to identify biocatalysts for lupeol biotransformation. Molecules 2010, 15:6140-6151.
10. Chatterjee T. Biotransformation of geraniol by Rhodococcus sp. strain GR3. Biotechnol Appl Biochem 2004, 39:303-306.
11. Chaturvedi D. Sesquiterpene lactones: structural diversity and their biological activities. Opportunity, challenge and scope of natural products in medicinal chemistry 2011, 313-334. Research Signpost, Trivandrum. V.K. Tiwari, B.B. Mishra (Eds.).
12. Chaturvedi D., Goswami A., Saikia P.P., Barua N.C., Rao P.G. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chem Soc Rev 2010, 39:435-454.
13. Chauhan S.S., Sharma M., Chauhan P.M.S. Trioxaquines: hybrid molecules for the treatment of malaria. Drug News Perspect 2010, 23:632-646.
14. Cimanga R.K., Tona G.L., Mesia G.K., Kambu O.K., Bakana D.P., Kalenda P.D.T., et al. Bioassay-guided isolation of antimalarial triterpenoid acids from the leaves of Morinda lucida. Pharm Biol 2006, 44:677-681.
15. Clark R.L. Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients. Birth Defects Res A 2012, 94:61-75.
16. Demyttenaere J.C.R., De Pooter H.L. Biotransformation of citral and nerol by spores of Penicillium digitatum. Flavour Fragance J. 1998, 13:173-176.
17. Demyttenaere J.C.R., Herrera M.d.C., De Kimpe N. Biotransformation of geraniol, nerol and citral by sporulated surface cultures of Aspergillus niger and Penicillium sp. Phytochemistry 2000, 55:363-373.
18. Dewick P.M. The mevalonate and deoxyxylulose phosphate pathways: terpenoids and steroids. Medicinal natural products: a biosynthetic approach 2001, 167-289. Wiley, Chichester. second edition.
19. Dondorp A.M., Yeung S., White L., Nguon C., Day N.P.J., Socheat D., et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 2010, 8:272-280.
20. Elmarakby S.A., el-Feraly F.S., Elsohly H.N., Croom E.M., Hufford C.D. Microbial transformation studies on arteannuin B. J Nat Prod 1987, 50:903-909.
21. Esmaeili A., Hashemi E. Biotransformation of myrcene by Pseudomonas aeruginosa. Chem Cent J 2011, 5:26.
22. Esmaeili A., Tavassoli A. Microbial transformation of citral by Penicillium sp. Acta Biochim Pol 2010, 57:265-268.
23. Fernández I., Robert A. Peroxide bond strength of antimalarial drugs containing an endoperoxide cycle. Relation with biological activity. Org Biomol Chem 2011, 9:4098-4107.
24. Fu S.-B., Yang J.-S., Cui J.-L., Feng X., Sun D.-A. Biotransformation of ursolic acid by an endophytic fungus from medicinal plant Huperzia serrata. Chem Pharm Bull 2011, 59:1180-1182.
25. García P.A., Oliveira A.B., Batista R. Occurrence, biological activities and synthesis of kaurane diterpenes and their glycosides. Molecules 2007, 12:455-483.
26. Gordi T., Lepist E.-I. Artemisinin derivatives: toxic for laboratory animals, safe for humans?. Toxicol Lett 2004, 147:99-107.
27. Goswami A., Saikia P.P., Barua N.C., Bordoloi M., Yadav A., Bora T.C., et al. Bio-transformation of artemisinin using soil microbe: direct C-acetoxylation of artemisinin at C-9 by Penicillium simpli[ci]ssimum. Bioorg Med Chem Lett 2010, 20:359-361.
28. Guo N., Zhao Y., Fang W.-S. Biotransformation of 3-oxo-oleanolic acid by Absidia glauca. Planta Med 2010, 76:1904-1907.
29. Hamzah J., Skinner-Adams T.S., Davis T.M.E. In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists. Acta Trop 2003, 87:345-353.
30. Harinasuta T., Suntharasamai P., Viravan C. Chloroquine-resistant falciparum malaria in Thailand. Lancet 1965, 286:657-660.
31. Hien T.T., White N.J. Qinghaosu. Lancet 1993, 341:603-608.
32. Jang H.-J., Yoon S.-H., Ryu H.-K., Kim J.-H., Wang C.-L., Kim J.-Y., et al. Retinoid production using metabolically engineered Escherichia coli with a two-phase culture system. Microb Cell Fact 2011, 10:59.
33. Kain K.C. Chemotherapy and prevention of drug-resistant malaria. Wilderness Environ Med 1995, 6:307-324.
34. Kaur K., Jain M., Kaur T., Jain R. Antimalarials from nature. Bioorg Med Chem 2009, 17:3229-3256.
35. Khalifa S.I., Baker J.K., Jung M., McChesney J.D., Hufford C.D. Microbial and mammalian metabolism studies on the semisynthetic antimalarial, deoxoartemisinin. Pharm Res 1995, 12:1493-1498.
36. Khamsan S., Liawruangrath B., Liawruangrath S., Teerawutkulrag A., Pyne S.G., Garson M.J. Antimalarial, anticancer, antimicrobial activities and chemical constituents of essential oil from the aerial parts of Cyperus kyllingia Endl. Rec Nat Prod 2011, 5:324-327.
37. Khor G.K., Uzir M.H. Saccharomyces cerevisiae: a potential stereospecific reduction tool for biotransformation of mono- and sesquiterpenoids. Yeast 2011, 28:93-107.
38. Klassen W. Introduction: development of the sterile insect technique for African malaria vectors. Malar J 2009, 8(Suppl. 2):11.
39. Klayman D.L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985, 228:1049-1055.
40. Krings U., Lehnert N., Fraatz M.A., Hardebusch B., Zorn H., Berger R.G. Autoxidation versus biotransformation of α-pinene to flavors with Pleurotus sapidus: regioselective hydroperoxidation of α-pinene and stereoselective dehydrogenation of verbenol. J Agric Food Chem 2009, 57:9944-9950.
41. Lee I.-S., ElSohly H.N., Croom E.M., Hufford C.D. Microbial metabolism studies of the antimalarial sesquiterpene artemisinin. J Nat Prod 1989, 52:337-341.
42. Li Q.-G., Peggins J.O., Fleckenstein L.L., Masonic K., Heiffer M.H., Brewer T.G. The pharmacokinetics and bioavailability of dihydroartemisin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 1998, 50:173-182.
43. Liao F. Discovery of artemisinin (qinghaosu). Molecules 2009, 14:5362-5366.
44. Liu J.-H., Chen Y.-G., Yu B.-Y., Chen Y.-J. A novel ketone derivative of artemisinin biotransformed by Streptomyces griseus ATCC 13273. Bioorg Med Chem Lett 2006, 16:1909-1912.
45. Loyola L.A., Bórquez J., Morales G., San-Martín A., Darias J., Flores N., et al. Mulinane-type diterpenoids from Azorella compacta display antiplasmodial activity. Phytochemistry 2004, 65:1931-1935.
46. Luo X.D., Shen C.C. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rev 1987, 7:29-52.
47. Mannan A., Ahmed I., Arshad W., Asim M.F., Qureshi R.A., Hussain I., et al. Survey of artemisinin production by diverse Artemisia species in northern Pakistan. Malar J 2010, 9:310.
48. Martin G.D.A., Durrant M.C., Reese P.B. A predictive cytochrome P450 monooxygenase functional model for generic hydroxylation by Rhizopus oryzae ATCC 11145. J Theor Comput Chem 2008, 7:421-433.
49. Medeiros S.F., Avery M.A., Avery B., Leite S.G.F., Freitas A.C.C., Williamson J.S. Biotransformation of 10-deoxoartemisinin to its 7β-hydroxy derivative by Mucor ramannianus. Biotechnol Lett 2002, 24:937-941.
50. Medhi B., Patyar S., Rao R.S., Byrav P., Prakash A. Pharmacokinetic and toxicological profile of artemisinin compounds: an update. Pharmacology 2009, 84:323-332.
51. Meunier B., Robert A. Heme as trigger and target for trioxane-containing antimalarial drugs. Acc Chem Res 2010, 43:1444-1451.
52. Moura I.C., Wunderlich G., Uhrig M.L., Couto A.S., Peres V.J., Katzin A.M., et al. Limonene arests parasite development and inhibits isoprenylation of proteins in Plasmodium falciparum. Antimicrob Agents Chemother 2001, 45:2553-2558.
53. Muraleedharan K.M., Avery M.A. Progress in the development of peroxide-based anti-parasitic agents. Drug Discov Today 2009, 14:793-803.
54. Musharraf S.G., Najeeb A., Khan S., Pervez M., Ali R.A., Choudhary M.I. Microbial transformation of 5α-hydroxycaryophylla-4(12), 8(13)-diene with Macrophomina phaseolina. J Mol Catal B: Enzym 2010, 66:156-160.
55. Nakase I., Lai H., Singh N.P., Sasaki T. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm 2008, 354:28-33.
56. Chemistry of terpenes and terpenoids 1972, Academic Press, London. A.A. Newman (Ed.).
57. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., Fukuda M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008, 359:2619-2620.
58. Nogueira C.R., Lopes L.M.X. Antiplasmodial natural products. Molecules 2011, 16:2146-2190.
59. O'Brien C., Henrich P.P., Passi N., Fidock D.A. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis 2011, 24:570-577.
60. Oliveira B.H., Strapasson R.A. Biotransformation of the monoterpene, limonene, by Fusarium verticill[i]oides. Braz Arch Biol Technol 2000, 43:11-14.
61. Omari A.A., Gamble C., Garner P. Artemether-lumefantrine for uncomplicated malaria: a systematic review. Trop Med Int Health 2004, 9:192-199.
62. Orabi K.Y., Galal A.M., Ibrahim A.-R.S., El-Feraly F.S., Khalifa S.I., El-Sohly H.N. Microbial metabolism of artemisitene. Phytochemistry 1999, 51:257-261.
63. Parshikov I.A., Miriyala B., Avery M.A., Williamson J.S. Hydroxylation of 10-deoxoartemisinin to 15-hydroxy-10-deoxoartemisinin by Aspergillus niger. Biotechnol Lett 2004, 26:607-610.
64. Parshikov I.A., Muraleedharan K.M., Avery M.A., Williamson J.S. Transformation of artemisinin by Cunninghamella elegans. Appl Microbiol Biotechnol 2004, 64:782-786.
65. Parshikov I.A., Muraleedharan K.M., Miriyala B., Avery M.A., Williamson J.S. Hydroxylation of 10-deoxoartemisinin by Cunninghamella elegans. J Nat Prod 2004, 67:1595-1597.
66. Parshikov I.A., Miriyala B., Muraleedharan K.M., Illendula A., Avery M.A., Williamson J.S. Biocatalysis of the antimalarial artemisinin by Mucor ramannianus strains. Pharm Biol 2005, 43:579-582.
67. Parshikov I.A., Miriyala B., Muraleedharan K.M., Avery M.A., Williamson J.S. Microbial transformation of artemisinin to 5-hydroxyartemisinin by Eurotium amstelodami and Aspergillus niger. J Ind Microbiol Biotechnol 2006, 33:349-352.
68. Pertino M., Schmeda-Hirschmann G., Santos L.S., Rodríguez J.A., Theoduloz C. Biotransformation of jatrophone by Aspergillus niger ATCC 16404. Z Naturforsch 2007, 62b:275-279.
69. Posner G.H., D'Angelo J., O'Neill P.M., Mercer A. Anticancer activity of artemisinin-derived trioxanes. Expert Opin Ther Pat 2006, 16:1665-1672.
70. Price R.N., Douglas N.M., Anstey N.M., von Seidlein L. Plasmodium vivax treatments: what are we looking for?. Curr Opin Infect Dis 2011, 24:578-585.
71. Rocha D., Takahashi J.A., Boaventura M.A.D. Di- and tri-hydroxylated kaurane derivatives from microbial transformation of ent-kaur-16-en-19-ol by Cephalosporium aphidicola and their allelopathic activity on Lactuca sativa (lettuce). Ecl Quím São Paulo 2009, 34:57-62.
72. Rustaiyan A., Nahrevanian H., Kazemi M. Isolation of artediffusin (tehranolide) as a new antimalarial agent. Asian J Chem 2011, 23:4810-4814.
73. Sá M.S., Costa J.F.O., Krettli A.U., Zalis M.G., Maia G.L.A., Sette I.M.F., et al. Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice. Parasitol Res 2009, 105:275-279.
74. Schaneberg B.T., Khan I.A. Comparison of extraction methods for marker compounds in the essential oil of lemon grass by GC. J Agric Food Chem 2002, 50:1345-1349.
75. Schmeda-Hirschmann G., Aranda C., Kurina M., Rodríguez J.A., Theoduloz C. Biotransformations of imbricatolic acid by Aspergillus niger and Rhizopus nigricans cultures. Molecules 2007, 12:1092-1100.
76. Severiano M.E., Simao M.R., Porto T.S., Martins C.H.G., Veneziani R.C.S., Furtado N.A.J.C., et al. Anticariogenic properties of ent-pimarane diterpenes obtained by microbial transformation. Molecules 2010, 15:8553-8566.
77. Simeó Y., Sinisterra J.V. Biotransformation of terpenoids: a green alternative for producing molecules with pharmacological activity. Mini Rev Org Chem 2009, 6:128-134.
78. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
79. Srivastava S., Luqman S., Fatima A., Darokar M.P., Negi A.S., Kumar J.K., et al. Biotransformation of artemisinin mediated through fungal strains for obtaining derivatives with novel activities. Sci Pharm 2009, 77:87-95.
80. Suksamrarn S., Panseeta P., Kunchanawatta S., Distaporn T., Ruktasing S., Suksamrarn A. Ceanothane- and lupane-type triterpenes with antiplasmodial and antimycobacterial activities from Ziziphus cambodiana. Chem Pharm Bull 2006, 54:535-537.
81. Sutherland J.B. Degradation of hydrocarbons by yeasts and filamentous fungi. Fungal Biotechnology in Agricultural, Food, and Environmental Applications 2004, 443-455. Marcel Dekker, New York. D.K. Arora (Ed.).
82. Tatineni R., Doddapaneni K.K., Dalavayi S., Kulkarni S.M., Mangamoori L.N. Microbacterium trichotecenolyticum enzyme mediated transformation of arteannuin B to artemisinin. Process Biochem 2006, 41:2464-2467.
83. Tchoumbougnang F., Zollo P.H.A., Dagne E., Mekonnen Y. In vivo antimalarial activity of essential oils from Cymbopogon citratus and Ocimum gratissimum on mice infected with Plasmodium berghei. Planta Med 2005, 71:20-23.
84. Thongnest S., Mahidol C., Sutthivaiyakit S., Ruchirawat S. Oxygenated pimarane diterpenes from Kaempferia marginata. J Nat Prod 2005, 68:1632-1636.
85. Titanji V.P.K., Zofou D., Ngemenya M.N. The antimalarial potential of medicinal plants used for the treatment of malaria in Cameroonian folk medicine. Afr J Tradit Complement Altern Med 2008, 5:302-321.
86. Uenojo M., Pastore G.M. β-Carotene biotransformation to obtain aroma compounds. Ciênc Tecnol Aliment Camp 2010, 30:822-827.
87. Velankar H.R., Heble M.R. Biotransformation of (L)-citronellal to (L)-citronellol by free and immobilized Rhodotorula minuta. Electron J Biotechnol 2003, 6:90-103.
88. Vroman J.A., Alvim-Gaston M., Avery M.A. Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials. Curr Pharm Des 1999, 5:101-138.
89. Walsh J.J., Coughlan D., Heneghan N., Gaynor C., Bell A. A novel artemisinin-quinine hybrid with potent antimalarial activity. Bioorg Med Chem Lett 2007, 17:3599-3602.
90. Wongsrichanalai C., Meshnick S.R. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis 2008, 14:716-719.
91. Zhan J., Guo H., Dai J., Zhang Y., Guo D. Microbial transformations of artemisinin by Cunninghamella echinulata and Aspergillus niger. Tetrahedron Lett 2002, 43:4519-4521.
92. Zhan J.-X., Zhang Y.-X., Guo H.-Z., Han J., Ning L.-L., Guo D.-A. Microbial metabolism of artemisinin by Mucor polymorphosporus and Aspergillus niger. J Nat Prod 2002, 65:1693-1695.
93. Zhang J., Cheng Z.-H., Yu B.-Y., Cordell G.A., Qiu S.X. Novel biotransformation of pentacyclic triterpenoid acids by Nocardia sp. NRRL 5646. Tetrahedron Lett 2005, 46:2337-2340.